Small Stocks BIG Returns

Numbers Don’t Lie … This Is As Good As It Gets
/

January 17, 2025

/

09:56 AM PST

Welcome to the weekend, folks, and what a wild Friday it was! Just when the market was about to pass the bearish point of no return, some stellar employment numbers swooped in to save the day. Friday was not only an encouraging end to the trading week, it was also the biggest daily gain we’ve seen in a while. So what does this mean for stocks, and what does it mean for you?

Biopolymer Product Line Expansion Sends Metabolix (Nasdaq:MBLX) to Different Trading Levels
/

January 17, 2025

/

09:53 AM PST

Metabolix, Inc. (Nasdaq:MBLX) Shares of MBLX soared $0.56 (or +52.34%) to $1.63, with a volume of 4,505,885 shares traded on Friday’s market activity. The company reported that it has launched Mvera(TM) B5011, a new film grade resin that allows for production of compostable, and highly transparent, film and bags. MBLX designed Mvera B5011 to meet international industrial standards for compostability,

Binary Options Trading – 5 Easy Ways to Reduce Risk
/

January 17, 2025

/

09:52 AM PST

Binary options trading is seen as a fast way of making money using speculation and risk spread as tools. Investors, new as well as experienced, usually want to play all-time big game with their money for which they cash upon the prevailing trends that provide them the scope to make profits. It is worth noticing that all speculations are not profit-yielding, so you need to learn ways to turn most of the market conditions in your favor.

Auxilium Pharmaceuticals (Nasdaq:AUXL) FDA Ok for Painful Curvature Injection, ZIOPHARM Oncology (Nasdaq:ZIOP) Positive Data
/

January 17, 2025

/

09:47 AM PST

Auxilium Pharmaceuticals, Inc. (Nasdaq:AUXL) The price of AUXL stock jumped $2.31 (or +11.95%) to $21.64, and 7,434,821 of its shares exchanged hands on Friday’s market activity. On intraday trading, AUXL reached a new 52 week high of $22.00 AUXL reported that the U.S. FDA has approved XIAFLEX(R) (collagenase clostridium histolyticum, or CCH), an in-office, biologic for the treatment of Peyronie’s disease, a condition that involves the development of collagen plaque, or scar tissue,

Christmas Rally Starts Monday! – My ETF Trading Strategies
/

January 17, 2025

/

09:46 AM PST

Tis the Season for the most powerful seasonality trade of the year! With the stock market up big in 2013 and most participants are speculating on a pullback in the next week or two, I have to say I am on the other side of that bet. Being a technical trader I focus on patterns, statistics and probabilities to power my ETF trading strategies. So with 37 years of stats the seasonality chart of the S&P 500 index paints a clear picture of what is likely to happen in December.

Crossroads Systems Surged On Future Q4 Financial Possibilities (CRDS)
/

January 17, 2025

/

09:43 AM PST

The HOT topic concerning Crossroads Systems, is its upcoming Q4 and Full Year 2013 financial results expected to be released December 12, 2013.